| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9992970526964d9f60672802eedb0ea2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
1998-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0db3384c5023e2192849968acbde3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_781f4c091b19a9548b46e7e264938293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75d709b6d32c9e0f1ecaeed16376ecd |
| publicationDate |
1999-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0922761-A1 |
| titleOfInvention |
Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| abstract |
Provided are a monoclonal antibody making it possible tondetect a native fibrin monomer, which are produced at theninitial state of blood coagulation, and soluble fibrin; anhybridoma; and an immunoassay for assaying the initial stage ofnblood coagulation highly sensitively, and promptly, using thenmonoclonal antibody. Using a fibrinogen analogous compound innblood as an immune source, cell fusion is carried out to preparena monoclonal antibody which is not reactive with fibrinogen andnis specifically and simultaneously reactive with a nativenfibrin monomer (that is, a fibrin monomer which is present in anbody fluid, in particular in blood, and is not solubilized) andnsoluble fibrin. The fibrin monomer analogous compound isnpreferably fibrinogen treated with bathroxobin, which is ansnake venom. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10081673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1832654-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1832654-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016024194-A1 |
| priorityDate |
1997-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |